Kinnate Biopharma

Kinnate Biopharma

Kinnate Biopharma

Kinnate Biopharma is a small molecule drug discovery company. We focus on precision oncology drugs that target specific genetic mutations and chromosomal abnormalities. https://www.kinnate.com
Founded
2018
Raised
$172.5M
Follow us
Alexa global traffic share
Latest funding
$98,000,000
Venture capital (Series C) - 2020
Foresite Capital RA Capital Management OrbiMed +9
$74,500,000
Venture capital (Series B) - 2019
Foresite Capital OrbiMed Eshelman Ventures +2
Team Size
1–10
Employees
$98,000,000 Venture capital (Series C)
FinSMEs

Kinnate Biopharma Closes $98M Series C Financing

$74,500,000 Venture capital (Series B)
Pulse 2.0 , FinSMEs

Precision Oncology Company Kinnate Biopharma Raises $74.5 Million